Neurotech is a clinical-stage biopharmaceutical development company focused on paediatric neurological disorders.neurotechinternational.com AustraliaJoined April 2013
Our Principal Investigator, Professor Russell Dale, who leads our Phase I/II PANDAS/PANS clinical trial, has had a new paper published in @Nature (Molecular Psychiatry).
This recognition underscores the calibre of clinical leadership guiding NTI164’s development and builds…
“We now have the clinical data, regulatory momentum, and leadership to deliver NTI164 to patients globally,” Chairman Mark Davies said. FY25 was a turning point,” Davies said. “With a strong clinical package, regulatory recognition, and an experienced team, Neurotech is…
"In my clinical practice, I’ve seen how full-spectrum cannabinoid therapies can profoundly improve the lives of children with autism, Rett syndrome, and PANS." – Dr. Bonni Goldstein MD, Neurotech Chief Medical Advisor (USA).
Dr. Goldstein supports NTI164, Neurotech’s consistent,…
The U.S. is considering moving #marijuana from a Schedule I to a Schedule III substance, a change that could make life a lot easier for companies working with #cannabinoid-based medicines.
While #NTI164 is already developed and trialled within Australia’s regulatory framework,…
Our Managing Director & CEO, Anthony Filippis joined today’s “Deal Making: The Real Story” panel at the 2025 Bioshares Biotech Summit, alongside fellow biotech leaders sharing real-world lessons on navigating transactions, partnerships, and growth.
Thanks to Bioshares for…
"Neurotech’s June quarter was marked by important clinical progress, growing international recognition, and further regulatory engagement for its lead investigational therapy #NTI164, a proprietary #CBDA-rich #cannabinoid formulation being developed for #paediatric neurological…
“NTI164 demonstrated safety and improved some clinical and functional outcomes in RTT [Rett],” Researchers wrote. “These improvements justify ongoing research into #NTI164, which may be a potential adjunct therapy in RTT.”
Media coverage by Bionews, Inc.
rettsyndromenews.com/news/cannabis-……
We’re pleased to share that our CEO, Dr Anthony Filippis, will be speaking at the 2025 Bioshares Biotech Summit, held 7–8 August in Hobart.
Anthony will take part in Session 3: Deal Making – The Real Story, a panel discussion exploring the complexities and practical realities of…
We've received a powerful caregiver statement highlighting the impact of #NTI164 in a child with moderate Autism Spectrum Disorder (#ASD):
“As a parent of a child diagnosed with moderate Autism Spectrum Disorder, I have observed significant and encouraging changes since…
In a recent @StockheadAU interview, our Chief Medical Advisor (USA), Dr. Bonni Goldstein, discusses NTI164 - our cannabinoid-based therapy currently in development for autism spectrum disorder, Rett Syndrome, and PANS/PANDAS.
Dr. Goldstein shares her journey from paediatric…
We've published our Phase I/II Rett syndrome clinical trial results in the peer-reviewed scientific journal, Journal of Paediatrics and Child Health.
The study, titled “Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) Improves Symptoms of Rett Syndrome: An…
Watch the latest @StockheadAU interview with Professor Michael Fahey, a leading Paediatric Neurologist and Clinical Geneticist at Monash Medical Centre, as he shares his experience using our #NTI164 drug in the treatment of #ASD and Rett syndrome. He discusses how NTI164 is…
We’ve appointed Dr. Bonni Goldstein as our Chief Medical Advisor USA. Dr. Goldstein brings more than 25 years of clinical experience, including 17 years focused exclusively on cannabinoid-based therapeutics. She is internationally recognised for her work treating thousands of…
We've been invited to share our clinical findings on NTI164 at the International @Rettsyndrome Foundation Scientific Meeting, 9–11 June in Boston.
Our Principal Investigator, Professor Carolyn Ellaway, will present both a poster and an oral presentation detailing outcomes from…
429 Followers 334 FollowingCanadian charity on a mission to restore brain health for everyone affected by PANS/PANDAS by improving health, delivering education, and accelerating research.
30 Followers 102 FollowingClinical psychologist, teaming up with neuroscience and AI to understand and support human minds.
LUMAĒN Project - work in progress...
104 Followers 1K Following❤️ God and Family
🇺🇸 Finance, Psichology and English Student
🐕🦺Servicios de Inglés y tecnología
💪 Passionate about Principles, Inner, Finance
11 Followers 96 FollowingOn a mission to hack the neuron and explore cutting-edge neurotech. Want the inside scoop? Subscribe to The NeuroCircuit for game-changing insights!
7K Followers 574 FollowingBiotech advisor @Pharmagellan. Professor of the Practice of Biotech @tufts_biology. Lurking here; posting at @franksdavid.bsky.social.
3K Followers 241 FollowingThe one to subjugate all shabby biotechs | German Biotech and Special Situation enthusiast | Disclaimer: Not financial advice. Might buy or sell any securities
5K Followers 702 FollowingBioPharma 10x Engineer. Full Time Trader/Investor. $GLSI $ARDX $VKTX $LUCD 95% of Positions. Not Investment Advice. Do your own Research.
3K Followers 822 FollowingOnly my thoughts/ideas. I may be Long or Short the names I am Tweeting about. My Tweets are not investment recommendations. Retweets do not equal endorsement.
4K Followers 284 FollowingSmall caps, shells, biotech. Assume all specs will fail; trade the stories and themes. Tweets are not financial advice. Always do your own research
6K Followers 228 Following💫 Full-Time ASX Capital Growth Investor & Trader (18yrs) Chartist & Fundamentalist ( Posts Are Personal Opinion Not Financial Advice) ZERO Tolerance for Trolls
2K Followers 2K FollowingLove or Fear 💖💕😊
Momentum / Trend following Trader.
Charts posted for educational purposes only.
Not investment or financial advice.
510 Followers 8K FollowingParent raising awareness of #PANDAS #PANS ~ #BrainInflammation in children triggered by #infection / #virus. #NoMoreLostChildren. #ChangeIsComing
6K Followers 1K FollowingOfficial X account for Aspect(Autism Spectrum Australia), at the forefront of national autism service provision, practice and research #aDifferentBrilliant
3K Followers 669 FollowingWe are transforming lives every day in our fight to treat and cure Rett syndrome and better the lives of families living with this devastating disorder.
761 Followers 932 FollowingORSA Canada is a volunteer, non-profit charity for parents, researchers and medial professionals. We advocate for all Canadians affected by Rett syndrome.
3K Followers 94 FollowingTrader trading trades in ASX small caps.
Not here for pips - looking for big movers only.
This is the new all-seeing funkman.
All IMO
38K Followers 366 FollowingASX Trader. Charting enthusiast. Position/Trend/Breakouts. No financial advice given please DYOR as at least 50% of what I bought has been losing trades
6K Followers 50 FollowingNews affecting the biotech industry and associated stocks. Includes #biotech trends, market analysis as well as mergers and acquisition news. cc: @TheStreet
50K Followers 2K FollowingMy tweets are my opinions and not a financial advice ✈️🏂🏄 mom, options trader, patriot 🇺🇸 from 🇧🇷 in Cali living the dream #stockonomics #TraderVerse
76K Followers 732 Following#Biotech Investor | Recovering Scientist | May have L/S position in names mentioned | Opinions are strictly my own and not intended as investment advice